Scientists find signs of waning antibody immunity to COVID-19 over time in England

Antibodies against the novel coronavirus declined rapidly in the population in England during the summer, suggesting protection after infection may not be long-lasting, researchers say.

Antibodies one aspect of murky coronavirus immunity picture

A research technician handles a sample from a volunteer while testing antibodies to see if they bind to the virus in a laboratory at Imperial College in London in July. It remains unclear what level of immunity antibodies provide against COVID-19. (Kirsty Wigglesworth/The Associated Press)

Antibodies against the novel coronavirus declined rapidly in the population in England during the summer, according to a preprint posted on Tuesday, suggesting protection after infection may not be long-lasting and raising the prospect of waning immunity in the community.

Scientists at Imperial College London have tracked antibody levels in the population in England following the first wave of COVID-19 infections in March and April.

Their study found that antibody prevalence based on finger-prick tests of blood fell by a quarter, from six per cent of the population around the end of June to just 4.4 per cent in September. That raises the prospect of decreasing population immunity ahead of a second wave of infections in recent weeks that has forced local lockdowns and restrictions.

Although immunity to the novel coronavirus is a complex and murky area and may be assisted by T cells as well as B cells, which can stimulate the quick production of antibodies following re-exposure to the virus, the researchers said the experience of other coronaviruses suggested immunity might not be enduring.

"We can see the antibodies and we can see them declining and we know that antibodies on their own are quite protective," Wendy Barclay, head of the Department of Infectious Disease at Imperial College London, told reporters.

"On the balance of evidence I would say, with what we know for other coronaviruses, it would look as if immunity declines away at the same rate as antibodies decline away, and that this is an indication of waning immunity at the population level."

University of Calgary microbiologist Craig Jenne, who was not involved in the research, said antibodies can start to fade in as little as eight weeks.

"People who get mildly sick, the body doesn't seem to think it's that severe, and we don't put a lot of resources into overcoming [the infection]," Jenne said. "Unfortunately [in] those people, it looks like the immunity fades much quicker."

Those for whom COVID-19 was confirmed with a gold standard PCR test had a less pronounced decline in antibodies, compared to people who had been asymptomatic and unaware of their original infection.

There was no change in the levels of antibodies seen in health-care workers, possibly due to repeated exposure to the virus.

Vaccine may be more protective

The study, which has not yet been peer reviewed to flag flaws, backs up findings from similar surveys in Germany. The German researchers found the vast majority of people didn't have COVID-19 antibodies, even in hot spots for the disease, and that antibodies might fade in those who do.

WATCH | The limits of pursuing herd immunity:

Push to pursue COVID-19 herd immunity called 'dangerous'

The National

5 months ago
A group of international experts push back against the Great Barrington Declaration and its pursuit of COVID-19 herd immunity, calling it “a dangerous fallacy unsupported by scientific evidence.” 2:05

World Health Organization spokesperson Tarik Jasarevic said that uncertainty over how long immunity would last, and the fact that most people had never had antibodies against the coronavirus in the first place, showed the need to break transmission chains.

"Acquiring this collective immunity just by letting the virus run through the population is not really an option," he told a UN briefing in Geneva.

Imperial's study was based on a survey of 365,000 randomly selected adults.

The rapid waning of antibodies did not necessarily have implications for the efficacy of vaccine candidates currently in clinical trials, Imperial's Barclay said.

"A good vaccine may well be better than natural immunity," she said.

Jen Gommerman, a professor of immunology at the University of Toronto, is studying antibody levels in response to the spike protein of the coronavirus in the saliva of people who recovered from COVID-19.

"If we can make a good antibody response to the virus, we should be able to make a good antibody response to the vaccine, and that antibody response should be reasonably durable," Gommerman said.

The caveat she said is that the data on how long the immune system's antibody response lasts is limited to six months so far. 

With files from CBC News

Add some “good” to your morning and evening.

A variety of newsletters you'll love, delivered straight to you.

Sign up now


To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.